Evidence map›Paper›PMID 40809952›Full record

ArticleEJHaem2025

Trends, Predictors, and Outcomes of Critically Ill Patients With Sickle Cell Disease in the United States.

Tochukwu Nzeako, Olayemi Adeniran, Saranjeet Kaur, Shreya Singh, Jen Wang, Ammar Alzoubi

Abstract read
In one paragraph

Article in EJHaem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tochukwu NzeakoDepartment of Internal Medicine Christiana Care Hospital Newark Delaware USA.
Olayemi AdeniranDepartment of Cardiovascular Diseases SUNY Downstate Health Sciences University Brooklyn New York USA.ORCID https://orcid.org/0000-0003-2684-2348
Saranjeet KaurDepartment of Medicine Touro College of Osteopathic Medicine Manhattan New York USA.
Shreya SinghDepartment of Medicine Touro College of Osteopathic Medicine Manhattan New York USA.
Jen WangDepartment of Hematology and Oncology Brookdale University Hospital Medical Center Brooklyn New York USA.ORCID https://orcid.org/0000-0002-9623-6645
Ammar AlzoubiDepartment of Hematology and Oncology Christiana Care Hospital Newark Delaware USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite recent advances in sickle cell disease (SCD) research and management, there remains very limited information available on critically ill SCD patients requiring intensive care units (ICUs). Methods: The National Inpatient Sample was queried using the International Classification of Diseases codes to identify critically ill patients with SCD requiring ICU admission. These patients were further stratified into those with and without adverse clinical events (ACEs). The study outcomes were the incidence of acute chest syndrome, cardiac arrest, hemodialysis, sepsis, shock, and transfusion. Results: Of 5941 patients admitted to the ICU, 2826 (47.6%) had ACE. Patients with ACE were likely to be older, male, white, rural, and have higher comorbidities. The prevalence of ICU admission increased by 126% ( Conclusion: There has been an increase in the prevalence of critically ill SCD patients requiring ICU care, with subsequent morbidity and mortality. Further research is needed to understand the underlying factors that drive these observed trends and increase mortality rates. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

adverse clinical eventscritically illintensive care unitsickle cell disease

Identifiers

PMID40809952
PMCPMC12345595

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.